Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis
暂无分享,去创建一个
[1] K. Amann,et al. CD40-CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure. , 2007, Atherosclerosis.
[2] S. Stock,et al. Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. , 2006, Arthritis and rheumatism.
[3] L. Pachman,et al. MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement. , 2006, Clinical immunology.
[4] M. Rewers,et al. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. , 2006, The international journal of biochemistry & cell biology.
[5] M. Indelman,et al. Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred , 2006, Journal of Human Genetics.
[6] A. Dyer,et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. , 2006, The Journal of pediatrics.
[7] E. Hoffman,et al. Fgfr4 Is Required for Effective Muscle Regeneration in Vivo , 2006, Journal of Biological Chemistry.
[8] Y. Ikari,et al. Vascular calcification in chronic kidney disease , 2006, Journal of Bone and Mineral Metabolism.
[9] I. Rosner,et al. Calcinosis in rheumatic diseases. , 2005, Seminars in arthritis and rheumatism.
[10] R. Guidoin,et al. Degenerative mineralization in the fibrous capsule of silicone breast implants , 2005, Journal of materials science. Materials in medicine.
[11] N. Mamalis,et al. Surface calcification of a 3-piece silicone intraocular lens in a patient with asteroid hyalosis: a clinicopathologic case report. , 2005, Ophthalmology.
[12] Stuart R. Stock,et al. Pathological calcifications studied with micro-CT , 2004, SPIE Optics + Photonics.
[13] A. Dyer,et al. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. , 2004, The Journal of rheumatology.
[14] P. Lachenbruch,et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. , 2004, Arthritis and rheumatism.
[15] F. Lioté,et al. Calcium pyrophosphate dihydrate and basic calcium phosphate crystalinduced arthropathies: Update on pathogenesis, clinical features, and Therapy , 2004, Current rheumatology reports.
[16] Saeed R. Khan. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies , 2004, Journal of Clinical and Experimental Nephrology.
[17] R. de Caterina,et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. , 2004, Journal of the American College of Cardiology.
[18] H. Katus,et al. A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice. , 2004, The American journal of pathology.
[19] R. Terkeltaub,et al. Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess. , 2004, Osteoarthritis and cartilage.
[20] J. Holton,et al. MHC Class I overexpression on muscles in early juvenile dermatomyositis. , 2004, The Journal of rheumatology.
[21] S. Stock,et al. Pathological Calcification in Juvenile Dermatomyositis (JDM): MicroCT and Synchrotron X-Ray Diffraction Reveal Hydroxyapatite with Varied Microstructures , 2004, Connective tissue research.
[22] V. Duance,et al. Does protein kinase R mediate TNF-α- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism? , 2003, Arthritis research & therapy.
[23] L. Chess,et al. Mechanisms of Cell-Mediated Myocytotoxicity in the Peripheral Blood of Patients with Inflammatory Myopathies , 2001, Journal of Clinical Immunology.
[24] A. Boskey,et al. FT-IR microscopic mappings of early mineralization in chick limb bud mesenchymal cell cultures , 1992, Calcified Tissue International.
[25] Kui Wang,et al. Effects of LDL, cholesterol, and their oxidized forms on the precipitation kinetics of calcium phosphates. , 2003, Clinical chemistry.
[26] B. Bennett,et al. Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. , 2003, Cardiovascular research.
[27] A. Dyer,et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. , 2003, Arthritis and rheumatism.
[28] H. Anderson. Matrix vesicles and calcification , 2003, Current rheumatology reports.
[29] R. Terkeltaub,et al. Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: New developments relevant to the clinician , 2003, Current rheumatology reports.
[30] R. Bode,et al. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.
[31] R. Sundel,et al. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. , 2002, Journal of the American Academy of Dermatology.
[32] S. Tan,et al. Lupus erythematosus panniculitis: a clinicopathologic study , 2002, International journal of dermatology.
[33] C. Magro,et al. Calciphylaxis: Emerging Concepts in Prevention, Diagnosis, and Treatment , 2002, Seminars in dialysis.
[34] A. Boskey. Pathogenesis of cartilage calcification: Mechanisms of crystal deposition in cartilage , 2002, Current rheumatology reports.
[35] Eric P. Hoffman,et al. Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis1 , 2002, The Journal of Immunology.
[36] M. Roman,et al. Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. , 2001, Current opinion in rheumatology.
[37] L. Pachman,et al. Expression of TNFα by muscle fibers in biopsies from children with untreated juvenile dermatomyositis : Association with the TNFα-308A allele , 2001 .
[38] P. Halverson,et al. Calcium crystal-induced inflammation. , 2001, Current opinion in rheumatology.
[39] M. Mukamel,et al. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. , 2001, The Journal of pediatrics.
[40] J. Hamada,et al. Analysis of calcium deposits in calcific periarthritis. , 2001, The Journal of rheumatology.
[41] J. Welsh,et al. Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.
[42] L. Pachman,et al. TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications , 2000 .
[43] R. Terkeltaub,et al. Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[44] C. Little,et al. Mechanisms involved in cartilage proteoglycan catabolism. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[45] L. Pachman,et al. Decreased Levels of CD54 (ICAM-1)-Positive Lymphocytes in the Peripheral Blood in Untreated Patients with Active Juvenile Dermatomyositis , 2000, Clinical Diagnostic Laboratory Immunology.
[46] I. Lundberg. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies , 2000, Current rheumatology reports.
[47] C. Canver,et al. Association of osteopontin with calcification in human mitral valves. , 2000, The Journal of cardiovascular surgery.
[48] T. Kirsch,et al. Matrix Vesicles Mediate Mineralization of Human Thyroid Cartilage , 2000, Calcified Tissue International.
[49] K. Mann,et al. Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[50] E. Hachulla,et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. , 1999, Medicine.
[51] M D McKee,et al. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. , 1999, Circulation research.
[52] L. Kuller,et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.
[53] P. Libby,et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. , 1999, The American journal of pathology.
[54] K. Kim,et al. A Case of Nodular Cystic Fat Necrosis: The End Stage Lesion Showing Calcification and Lipomembranous Changes , 1998, The Journal of dermatology.
[55] G. Vogel. Bacteria to Blame for Kidney Stones? , 1998, Science.
[56] J. Tomashefski,et al. Destruction and loss of bronchial cartilage in cystic fibrosis. , 1998, Human pathology.
[57] P. Wattanakrai,et al. Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: Report of two cases , 1997, The Australasian journal of dermatology.
[58] F. Miller,et al. Classification and treatment of the juvenile idiopathic inflammatory myopathies. , 1997, Rheumatic diseases clinics of North America.
[59] R. Terkeltaub,et al. Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation. , 1997, Arthritis and rheumatism.
[60] A. Veis,et al. Identification of specific calcium-binding noncollagenous proteins associated with glutaraldehyde-preserved bovine pericardium in the rat subdermal model. , 1997, Journal of biomedical materials research.
[61] P. Plotz,et al. The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases. , 1997, Proceedings of the Association of American Physicians.
[62] L. N. Wu,et al. Physicochemical Characterization of the Nucleational Core of Matrix Vesicles* , 1997, The Journal of Biological Chemistry.
[63] A. Carpentier,et al. Osteopontin is associated with bioprosthetic heart valve calcification in humans. , 1997, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[64] C. Mautalen,et al. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. , 1996, The Journal of rheumatology.
[65] I. Febrer,et al. Partial Lipodystrophy Associated with Juvenile Dermatomyositis: Report of Two Cases , 1996, Pediatric dermatology.
[66] A. Prieur,et al. Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. , 1996, The Journal of rheumatology.
[67] R. Terkeltaub,et al. Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[68] M. Ferguson,et al. Osteopontin is expressed in human aortic valvular lesions. , 1995, Circulation.
[69] P. Weissberg,et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[70] L. Sigal. Summary of the Fifth International Congress on Lyme Borreliosis. , 1994, Arthritis and rheumatism.
[71] A. Martini,et al. Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis. , 1993, Archives of disease in childhood.
[72] M. Dalakas,et al. A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.
[73] E. Silverman,et al. Treatment of dermatomyositis with intravenous gammaglobulin. , 1991, The American journal of medicine.
[74] V. Dubowitz,et al. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy , 1990, Journal of the Neurological Sciences.
[75] Olson Ny,et al. Adjunctive use of hydroxychloroquine in childhood dermatomyositis. , 1989 .
[76] P. Robey. The Biochemistry of Bone , 1989 .
[77] P. Bullough,et al. Calcium-acidic phospholipid-phosphate complexes in human hydroxyapatite-containing pathologic deposits. , 1988, The American journal of pathology.
[78] J. Barré,et al. [Value of cyclosporin A in dermatomyositis in a child]. , 1988, Archives francaises de pediatrie.
[79] T. Masuda,et al. LIGHT AND ELECTRON MICROSCOPIC OBSERVATION ON THE PROCESS OF TISSUE CALCIFICATION IN A CASE OF PARATHYROID ADENOMA , 1987, Acta pathologica japonica.
[80] F. M. McLean,et al. Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. Effect of selective release of membrane-bound alkaline phosphatase and treatment with isosmotic pH 6 buffer. , 1986, The Journal of biological chemistry.
[81] C. Blane,et al. Patterns of calcification in childhood dermatomyositis. , 1984, AJR. American journal of roentgenology.
[82] C. Blane,et al. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. , 1983, The Journal of pediatrics.
[83] A. Boskey,et al. Chemical, microscopic, and ultrastructural characterization of the mineral deposits in tumoral calcinosis. , 1983, Clinical orthopaedics and related research.
[84] L. Pachman,et al. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis. , 1983, The Journal of rheumatology.
[85] D. Doyle. Tissue calcification and inflammation in osteoarthritis , 1982, The Journal of pathology.
[86] K. Pickrell,et al. Surgical Treatment of Subcutaneous Calcifications of Polymyositis or Dermatomyositis , 1980, Annals of plastic surgery.
[87] R. L. Linscheid,et al. Surgical treatment of calcinosis cutis in the upper extremity. , 1977, The Journal of hand surgery.
[88] B. Banker. DERMATOMYOSITIS OF CHILDHOOD: ULTRASTRUCTURAL ALTERATIONS OF MUSCLE AND INTRAMUSCULAR BLOOD VESSELS , 1975, Journal of neuropathology and experimental neurology.